Document is current

Any future updates will be listed below

Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells

Crossref DOI link: https://doi.org/10.1186/s13045-017-0530-z

Published Online: 2017-10-06

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark